Clinical trial · Interventional
Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung Cancer
Electromagnetic Navigation Guided Versus CT-guided Transthoracic Needle Aspiration (TTNA) in the Diagnosis of Early Peripheral Lung Cancer, a Randomized Open Label Trial
NCT03802266CI-TRIAL-00036501unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare Electromagnetic navigation guided with CT-guided transthoracic needle aspiration (TTNA) in the diagnosis of pulmonary peripheral nodule. Primary endpoints：Diagnostic rate Secondary endpoints：operating time、adverse events Study design: Multicenter、randomized、open lebel
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CT-guided Transthoracic Needle Aspiration | Device | — | UNRESOLVED |
| Electromagnetic Navigation guided transthoracic needle aspiration | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Electromagnetic Navigation group
- description
- Electromagnetic Navigation Guided Transthoracic Needle Aspiration
- interventionNames
- Device: Electromagnetic Navigation guided transthoracic needle aspiration
- type
- ACTIVE_COMPARATOR
- label
- CT group
- description
- CT-guided Transthoracic Needle Aspiration
- interventionNames
- Device: CT-guided Transthoracic Needle Aspiration
Primary outcomes (1)
- measure
- Diagnostic rate
- timeFrame
- 18 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with 0.8-3 cm, high-risk pulmonary peripheral nodules that need biopsy for pathological diagnosis; 2. Patients who are older than 18 year-old; 3. Patients voluntarily join the study and give written informed consent for the study. Exclusion Criteria: 1. Chest CT scan shows that the pulmonary nodule is pure ground glass opacity. 2. Large blood vessels or important structures on the puncture path of peripheral lung tumors； 3. Severe cardiopulmonary dysfunction and other indications that can't receive bronchoscopy.
References
Publications (0)
Data not yet available
No reference posted for this study.